These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20193266)

  • 1. Images for diagnosis. CD4+CD56+ hematodermic neoplasm in a child.
    Guo X; Li Q; Zhou CY
    Chin Med J (Engl); 2010 Feb; 123(3):379-81. PubMed ID: 20193266
    [No Abstract]   [Full Text] [Related]  

  • 2. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4(+)/CD56(+) hematodermic neoplasm.
    Carlesimo M; Mari E; Cortesi G; Orsini D; Narcisi A; Cox MC; Ruco L; Pulcini F; Camplone G
    Eur J Dermatol; 2011; 21(2):291-2. PubMed ID: 21382786
    [No Abstract]   [Full Text] [Related]  

  • 4. CD4+ CD56+ hematodermic neoplasm.
    Cibull TL; Thomas AB; O'Malley DP; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):59-61. PubMed ID: 17284963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous CD4+/CD56+ hematodermic neoplasm.
    Zindanci I; Kavala M; Buyukbabani N; Kocaturk E; Koc M
    Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma).
    Weaver J; Hsi ED
    J Cutan Pathol; 2008 Oct; 35(10):975-7. PubMed ID: 18822062
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
    Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
    Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
    Hamadani M; Magro CM; Porcu P
    Br J Haematol; 2008 Jan; 140(2):122. PubMed ID: 17991297
    [No Abstract]   [Full Text] [Related]  

  • 10. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
    Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
    J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4/CD56 hematodermic neoplasm: a report of three cases.
    Ji H; Wang L; Li D; Zhang W; Wan C; Xu C; Li G
    Int J Dermatol; 2009 Jul; 48(7):743-8. PubMed ID: 19570082
    [No Abstract]   [Full Text] [Related]  

  • 13. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
    Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
    Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
    J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
    Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
    Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroa-like lymphoma with CD56 expression.
    Doeden K; Molina-Kirsch H; Perez E; Warnke R; Sundram U
    J Cutan Pathol; 2008 May; 35(5):488-94. PubMed ID: 17976208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CD56-positive 'natural killer'/T-cell lymphoma].
    Bekkenk MW; Willemze R
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1524-5. PubMed ID: 11569462
    [No Abstract]   [Full Text] [Related]  

  • 20. Fine-needle aspiration cytology of blastic natural killer-cell lymphoma (CD4+ CD56+ hematodermic neoplasm).
    Wu HH; Ren R; Roepke JE
    Diagn Cytopathol; 2004 Apr; 30(4):268-70. PubMed ID: 15048964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.